Regulation of Bcl-2 Expression by Dihydrotestosterone in Hormone Sensitive LNCaP-FGC Prostate Cancer Cells-Reference-Cited by-同舟云学术

Regulation of Bcl-2 Expression by Dihydrotestosterone in Hormone Sensitive LNCaP-FGC Prostate Cancer Cells

Published:2003-04 Issue:4 Volume:169 Page:1553-1557
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

BRUCKHEIMER ELIZABETH M.¹,SPURGERS KEVIN¹,WEIGEL NANCY L.¹,LOGOTHETIS CHRISTOPHER¹,McDONNELL TIMOTHY J.¹

Affiliation:

1. From the Departments of Molecular Pathology and Genitourinary Medical Oncology, University of Texas M. D. Anderson Cancer Center and Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland;Huggins;Arch Surg,1941

2. A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinoma;Sinha;Cancer,1977

3. Deletion of cells by apoptosis during castration-induced involution of the rat prostate;Kerr;Virchows Arch B Cell Pathol,1973

4. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer;McDonnell;Cancer Res,1992

5. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo;Raffo;Cancer Res,1995

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies;American Journal of Clinical Oncology;2021-05-12

2. Lack of Androgen Receptor Expression Selects for Basal-Like Phenotype and Is a Predictor of Poor Clinical Outcome in Non-Metastatic Triple Negative Breast Cancer;Frontiers in Oncology;2020-07-28

3. Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer;Clinical Cancer Research;2019-12-05

4. Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma;Clinical Cancer Research;2019-11-26

5. Anti-Cancer Effect of Lambertianic Acid by Inhibiting the AR in LNCaP Cells;International Journal of Molecular Sciences;2016-07-07